Atorvastatin Calcium Tablet, Film Coated
Product Images NDC 77771-453

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Atorvastatin Calcium (NDC 77771-453). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Radha Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Atorvastatin-10mg-1000tab (Atorvastatin 10mg 1000tab)

Packaging label for Atorvastatin Calcium Tablets USP, 10 mg strength, film-coated oral tablets. The label indicates a quantity of 1,000 tablets and is marked Rx Only. Manufactured by ScieGen Pharmaceuticals, Inc. and distributed by Radha Pharmaceuticals, Inc. The label includes storage instructions and a barcode.*

FDA Label Image

Atorvastatin-10mg-90tab (Atorvastatin 10mg 90tab)

Label for Atorvastatin Calcium Tablets, USP 10 mg film-coated tablets. The label indicates a quantity of 90 tablets, prescription only, manufactured by ScieGen Pharmaceuticals, Inc., and distributed by Radha Pharmaceuticals, Inc. Storage instructions and safety warnings are included, along with a barcode and the NDC number 77771-451-90.*

FDA Label Image

Atorvastatin-20mg-500tab (Atorvastatin 20mg 500tab)

Atorvastatin Calcium Tablets, USP, 20 mg film-coated tablets. The label indicates a package of 500 tablets for oral use, prescription only, manufactured by ScieGen Pharmaceuticals, Inc., and distributed by Radha Pharmaceuticals, Inc. It includes storage instructions and a barcode with NDC 77771-452-05.*

FDA Label Image

Atorvastatin-20mg-90tab (Atorvastatin 20mg 90tab)

Label for Atorvastatin Calcium Tablets, USP 20 mg by Radha Pharmaceuticals, Inc. The label indicates a package of 90 film-coated tablets for oral use. It includes storage instructions, dosage guidance, manufacturer and distributor information, and the NDC 77771-452-90 barcode.*

FDA Label Image

Atorvastatin-40mg-1000tab (Atorvastatin 40mg 1000tab)

Label for Atorvastatin Calcium Tablets, USP 40 mg film-coated tablets. The packaging indicates a quantity of 1,000 tablets, prescription only. Manufactured by ScieGen Pharmaceuticals, Inc. and distributed by Radha Pharmaceuticals, Inc., Hauppauge, NY. Includes storage instructions and a barcode, with a note stating "NO VARNISH."*

FDA Label Image

Atorvastatin-40mg-90tab (Atorvastatin 40mg 90tab)

A packaging label for Atorvastatin Calcium Tablets, USP 40 mg, film-coated oral tablets. The label specifies a quantity of 90 tablets and is marked Rx Only. It includes manufacturer information for ScieGen Pharmaceuticals, Inc. and distributor Radha Pharmaceuticals, Inc. The label also features a barcode and storage instructions to keep the medication out of children's reach.*

FDA Label Image

Atorvastatin-80mg-500tab (Atorvastatin 80mg 500tab)

Label for Atorvastatin Calcium Tablets, USP 80 mg film-coated oral tablets. The container holds 500 tablets and is labeled Rx only. The label shows the NDC code 77771-454-05 and is distributed by Radha Pharmaceuticals, Inc., Hauppauge, NY. Additional storage and safety information is printed, and the label states no varnish is applied.*

FDA Label Image

Atorvastatin-80mg-90tab (Atorvastatin 80mg 90tab)

Label for Atorvastatin Calcium Tablets USP 80 mg, film-coated oral tablets. The package contains 90 tablets and is marked Rx Only. The label states manufacturing by ScieGen Pharmaceuticals, Inc. and distribution by Radha Pharmaceuticals, Inc. Dosage instructions and storage information are partially visible, with a note to keep medication out of reach of children.*

FDA Label Image

Chemical-structure (Chemical Structure)

Chemical structure of atorvastatin calcium, showing the molecular arrangement including the calcium ion and associated water molecules as part of the complex.*

FDA Label Image

Figure-01 (Figure 1)

A line graph showing cumulative incidence percentage over 3.5 years comparing Atorvastatin and Placebo. The graph illustrates a lower incidence with Atorvastatin compared to Placebo, with a hazard ratio (HR) of 0.64 (0.50-0.83) and a p-value of 0.0005, indicating statistical analysis results.*

FDA Label Image

Figure-02 (Figure 2)

A cumulative hazard plot showing the time to first primary endpoint over four years of follow-up comparing placebo and atorvastatin treatment groups. The x-axis represents years, and the y-axis shows cumulative hazard percentage. The graph indicates lower hazard in the atorvastatin group versus placebo, with a hazard ratio of 0.63 (0.48-0.83) and p=0.001.*

FDA Label Image

Figure-03 (Figure 3)

A line chart comparing the percentage of subjects experiencing an event over time for Atorvastatin 10 mg and 80 mg dosages. The x-axis represents time to first major cardiovascular endpoint in years, ranging from 0 to 5 years. The y-axis shows the percentage of subjects experiencing the event, ranging from 0 to 0.2%. The chart includes hazard ratio (HR 0.78 with 95% confidence interval 0.69-0.89) and a p-value of 0.0002.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.